Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes

Diabetes Obes Metab. 2024 Feb;26(2):785-789. doi: 10.1111/dom.15365. Epub 2023 Nov 21.
No abstract available

Keywords: GIP; GLP-1; clinical trial; dyslipidaemia; type 2 diabetes.

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Gastric Inhibitory Polypeptide
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Lipids
  • Tirzepatide

Substances

  • Tirzepatide
  • Gastric Inhibitory Polypeptide
  • Lipids
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents

Grants and funding